Anderson Hoagland & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Anderson Hoagland & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-32,694	Closed	-$2.39M	–	131
2023 Q3	$2.39M	Buy	32,694 +95	+0.3%	+$7.59K	0.32%	78
2023 Q2	$2.71M	Sell	32,599 -180	-0.5%	-$15.1K	0.35%	75
2023 Q1	$2.5M	Sell	32,779 -160	-0.5%	-$13.3K	0.36%	73
2022 Q4	$2.8M	Sell	32,939 -213	-0.6%	-$17.2K	0.41%	70
2022 Q3	$2.63M	Buy	33,152 +16,797	+103%	+$1.42M	0.42%	65
2022 Q2	$1.36M	Sell	16,355 -9,938	-38%	-$746K	0.21%	87
2022 Q1	$2.36M	Buy	26,293 +21	+0.1%	+$1.94K	0.3%	71
2021 Q4	$2.42M	Buy	26,272 +289	+1%	+$34.9K	0.32%	76
2021 Q3	$3.27M	Buy	25,983 +1,035	+4%	+$133K	0.42%	62
2021 Q2	$3.38M	Buy	24,948 +432	+2%	+$56.8K	0.43%	60
2021 Q1	$3.33M	Sell	24,516 -1,949	-7%	-$292K	0.47%	57
2020 Q4	$3.73M	Buy	+26,465	New	+$3.39M	0.59%	50

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

CHP

Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Anderson Hoagland & Co's XBI Position: Q4 2023 in Review

Anderson Hoagland & Co sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 32,694 shares — an estimated $2.39M sold.

Anderson Hoagland & Co first reported a position in XBI in Q4 2020 and held it in 12 quarters. The position peaked at $3.73M in Q4 2020. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

Anderson Hoagland & Co reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
Anderson Hoagland & Co sold 32,694 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $2.39M.
Anderson Hoagland & Co first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 12 quarters.
Anderson Hoagland & Co's State Street SPDR S&P Biotech ETF position peaked at $3.73M in Q4 2020.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Anderson Hoagland & Co's 13F filing for Q4 2023, filed 17 Jan 2024.